These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29669808)

  • 41. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots.
    Knox P; Crooks S; Scaife MC; Patel S
    J Cell Physiol; 1987 Sep; 132(3):501-8. PubMed ID: 2958486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of plasminogen-plasmin system in cancer.
    Kwaan HC; McMahon B
    Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two types of receptors for human plasminogen on group G streptococci.
    Ullberg M; Karlsson I; Wiman B; Kronvall G
    APMIS; 1992 Jan; 100(1):21-8. PubMed ID: 1371393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasminogen interaction and activation on Streptococcus mutans surface.
    Urdaneta L; Vanegas G; Premoli G; Avilan L
    Oral Microbiol Immunol; 2004 Aug; 19(4):257-61. PubMed ID: 15209997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
    Bazzi ZA; Lanoue D; El-Youssef M; Romagnuolo R; Tubman J; Cavallo-Medved D; Porter LA; Boffa MB
    BMC Cancer; 2016 May; 16():328. PubMed ID: 27221823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK; Olsson AK; Hulett MD; Parish CR
    Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents.
    Farrehi PM; Zhu Y; Fay WP
    J Thromb Thrombolysis; 2001 Dec; 12(3):273-81. PubMed ID: 11981110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
    Ajjan RA; Gamlen T; Standeven KF; Mughal S; Hess K; Smith KA; Dunn EJ; Anwar MM; Rabbani N; Thornalley PJ; Philippou H; Grant PJ
    Blood; 2013 Jul; 122(1):134-42. PubMed ID: 23699598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of annexin II tetramer in plasminogen activation.
    Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
    Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi.
    Klempner MS; Noring R; Epstein MP; McCloud B; Hu R; Limentani SA; Rogers RA
    J Infect Dis; 1995 May; 171(5):1258-65. PubMed ID: 7751701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The elastase-mediated pathway of fibrinolysis.
    Machovich R; Owen WG
    Blood Coagul Fibrinolysis; 1990; 1(1):79-90. PubMed ID: 2151710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system.
    Albo D; Berger DH; Wang TN; Hu X; Rothman V; Tuszynski GP
    Surgery; 1997 Aug; 122(2):493-9; discussion 499-500. PubMed ID: 9288157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
    Carr ME; Alving BM
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.